Principal investigator for cell therapy team – Hematooncology and Immunotherapy

 

The Department of Hematooncology of the Faculty of Medicine, University of Ostrava announces the selection procedure:

Principal investigator for cell therapy team – Hematooncology and Immunotherapy

 


New Position PI Cell Therapy

 

5 years duration, full-time, (NOTE: Possibility to extend the stay depending on additional successful funding)

 

University/Department:

Location:

Research field:

 

Our research:

 

Job description:

 

Benefits

Salary:

We also offer:

 

Selection process

Important Dates:

 

Formal requirements

The candidate will send the following documents.

The evaluation committee will carry out the first round of the selection process by assessing the submitted documents. The applications will be evaluated continuously until 5th March 2022.

The successful candidates will be invited to the second round of the selection (in English, in person, or online). The employer is entitled to cancel the tender without giving any reasons or not to select any candidates.

 

Contact:

e-mail: info.bcrg@fno.cz

Blood Cancer Research Group: www.bcrg.cz

University of Ostrava: http://www.osu.eu

                                                                  

Offer Requirements

ENGLISH: Proficient

 

Skills/Qualifications

Eligibility and Selection Criteria

 

 

10.2.2022


Back